European Primary Care Cardiovascular Society

Results for oral PCSK9 inhibitor promising to proceed to phase 3 trials

3' education - Mar. 9, 2023 - Prof. Christie Ballantyne, MD - Houston, TX, USA

Educational information

This video was recorded at the Congress of the American College of Cardiology (ACC) 2023 in New Orleans, LA, USA.


Christie Ballantyne MD, cardiologist, and Professor of Medicine at Baylor College of Medicine, Houston, Texas, USA.


This recording was independently developed under auspices of EPCCS. The views expressed in this recording are those of the individual presenters and do not necessarily reflect the views of EPCCS.

Read our summary of this trial

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: